Serotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: Baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide

Clinical and Vaccine Immunology

Volumn 18, Issue 6, 2011, Pages 1028-1030

  Ceyhan, Mehmet ^a   Gurler, Nezahat ^b   Yaman, Akgun ^c   Ozturk, Candan ^d   Oksuz, Lutfiye ^b   Ozkan, Sengul ^e   Keser, Melike ^f   Salman, Nuran ^b   Alhan, Emre ^c   Esel, Duygu ^g   Gultekin, Meral ^h   Camcioglu, Yildiz ^b   Gul, Mustafa ⁱ   Sorguc, Yelda ^j   Aydemir, Sohret ^k   Gunaydin, Murat ^l   Yakupogullari, Yusuf ^m   Kizirgil, Ahmet ⁿ  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c CUKUROVA UNIVERSITY   (Turkey)

^d MERSIN UNIVERSITY   (Turkey)

^e DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^f SELCUK UNIVERSITY   (Turkey)

^g ERCIYES UNIVERSITY   (Turkey)

^h AKDENIZ UNIVERSITY   (Turkey)

ⁱ KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^j Behcet Uz Children's Hospital   (Turkey)

^k EGE UNIVERSITY   (Turkey)

^l ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^m MALATYA STATE HOSPITAL   (Turkey)

ⁿ FIRAT UNIVERSITY   (Turkey)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DRUG SCREENING; HUMAN; IMMUNIZATION; INVASIVE SPECIES; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE; SPECIES COMPARISON; STREPTOCOCCUS PNEUMONIAE; TURKEY (REPUBLIC);

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; HUMANS; INFANT; INFANT, NEWBORN; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TURKEY;

EID: 79957986282     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00526-10     Document Type: Article

References (31)

1. Black, S., et al. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19:187-195.
2. Centers for Disease Control and Prevention (CDC). 2008. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction - eight states, 1998-2005. MMWR Morb. Mortal. Wkly. Rep. 57:144-148.
3. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial disk susceptibility tests, 10th ed. Approved standard. Clinical and Laboratory Standards Institute, Wayne, PA.
4. de la Campa, A. G., et al. 2009. Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain. Emerg. Infect. Dis. 15:905-911.
5. Durando, P., et al. 2009. Universal childhood immunization against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy. Vaccine 27:3459-3462.
6. Feikin, D. R., and K. P. Klugman. 2002. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin. Infect. Dis. 35:547-555.
7. Feikin, D. R., et al. 2005. Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin. Infect. Dis. 41:481-487.
8. Grijalva, C. G., et al. 2007. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the U. S. A.: a time-series analysis. Lancet 369:1179-1186.
9. Hausdorff, W. P., R. Hajjeh, A. Al-Mazrou, A. Shibl, M. Soriano-Gabarro, and the Middle East & North Africa Vaccine-Preventable Diseases Regional Advisory Group. 2007. The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) region - current status and needs. Vaccine 25:1935-1944.
10. Imöhl, M., R. R. Reinert, and M. van der Linden. 2009. Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of age. Clin. Microbiol. Infect. 15:1008-1012.
11. Imöhl, M., R. R. Reinert, and M. van der Linden. 2010. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states. Int. J. Med. Microbiol. 300:237-247.
12. Jacobs, M. R., C. E. Good, S. Bajaksouzian, and A. R. Windau. 2008. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin. Infect. Dis. 47:1388-1395.
13. Jefferson, T., E. Ferroni, F. Curtale, P. Giorgi Rossi, P. Borgia. 2006. Streptococcus pneumoniae in Western Europe: serotype distribution and incidence in children less than 2 years old. Lancet Infect. Dis. 6:405-410.
14. Johnson, H. L., et al. 2010. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the Pneumococcal Global Serotype Project. PLoS Med. 7:e1000348. doi:10.1371/journal.pmed.1000348.
15. Kyaw, M. H., et al. 2006. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354:1455-1463. (Erratum: 355:638.)
16. Mahjoub-Messai, F., et al. 2009. Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal vaccination for French children. J. Clin. Microbiol. 47:837-840.
17. Ministry of Health of Turkey General Directorate of Primary Health Care Services. 1 December 2010, accession date. Genişletilmiş Baǧişiklama Programi Genelgesi. http://www.saglik.gov.tr/TR/belge/ 1-8187/genisletilmis-bagisiklama-programi-genelgesi-2009.html.
18. Mokaddas, E. M., V. O. Rotimi, and M. J. Albert. 2008. Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention. Clin. Vaccine Immunol. 15: 203-207.
19. Reference deleted.
20. Pilishvili, T., et al. 2010. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J. Infect. Dis. 201:32-41.
21. Reinert, R. R. 2004. Pneumococcal conjugate vaccines - a European perspective. Int. J. Med. Microbiol. 294:277-294.
22. Roche, P. W., et al. 2008. Invasive pneumococcal disease in Australia, 2006. Commun. Dis. Intell. 32:18-30.
23. Rose, M., and S. Zielen. 2009. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe. Expert Rev. Vaccines 8:1351-1364.
24. Schranz, J. 2009. Pneumococcal conjugate vaccines: what do we know and what do we need? Procedia Vaccinol. 1:189-205.
25. Sener, B., et al. 2007. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004-2005. J. Antimicrob. Chemother. 60:587-593.
26. United Nations Children's Fund/World Health Organization. 1 April 2011, accession date. Pneumonia: the forgotten killer of children. http://www.unicef.org/mdg/mortalitymultimedia/Pneumonia-The-Forgotten-Killer-of- Children.pdf.
27. Varon, E., C. Janoir, and L. Gutmann. 2008. Rapport d'activité 2008. Centre National de Référence des Pneumocoques, Créteil, France. http://www.invs.sante.fr/surveillance/cnr/rapports- pneumocoques2008.pdf.
28. Vestrheim, D. F., et al. 2010. Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule. Vaccine 28:2214-2221.
29. Vestrheim, D. F., et al. 2008. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine 26:3277-3281.
30. World Health Organization. 2007. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly. Epidemiol. Rec. 82: 93-104.
31. Yalçin, I., et al. 2006. Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001-2004. Eur. J. Pediatr. 165:654-657.